Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Frontiers in Medicine|February 24, 2022
Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and <i>SMARCB1/INI1</i> Deficiency, Broadening the Spectrum of Medullary CarcinomaMarina Valeri, Miriam Cieri, Grazia Maria Elefante, et al.
BJUI Compass|April 27, 2022
Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label studyRodolfo Hurle, Paolo Casale, Emanuela Morenghi, et al.
Urologic Oncology|October 15, 2021
Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment startRodolfo Hurle, Giorgio Guazzoni, Piergiuseppe Colombo, et al.
European Urology Open Science|August 2, 2021
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center ExperienceMarco Paciotti, Paolo Casale, Piergiuseppe Colombo, et al.
Journal of Neuro-Oncology|October 13, 2006
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiformeGiuseppe Luigi Banna, Daniela Bettio, Marta Scorsetti, et al.
Cancers|March 28, 2025
Assessment of the Mechanisms of Action of Eribulin in Patients with Advanced Liposarcoma Through the Evaluation of Radiological, Functional, and Tissue Responses: A Prospective Monocentric Study (Malibu Study)Maria Susanna Grimaudo, Federico D'Orazio, Salvatore Lorenzo Renne, et al.
Korean Journal of Urology|June 17, 2015
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancerGianluigi Taverna, Fabio Grizzi, Piergiuseppe Colombo, et al.
Cancer Research|November 4, 2015
Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1Roberta Mazzieri, Giovanni Pietrogrande, Laura Gerasi, et al.
Frontiers in Medicine|November 25, 2024
Case report: STRN3-NTRK3 fusion in uterine sarcoma with spleen metastasis: a new variant in the spectrum of NTRK-rearranged tumorsPiergiuseppe Colombo, Giuseppina Adriana Buonamassa, Anita Giulianini, et al.
Frontiers in Oncology|June 6, 2022
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective TrialRoberto Contieri, Giovanni Lughezzani, Nicolò Maria Buffi, et al.
Pageof 12